UK markets close in 42 minutes

Biodesix, Inc. (BDSX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.6600+0.0900 (+5.73%)
As of 10:43AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 65.43M
Enterprise value 61.39M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.45
Price/book (mrq)8.41
Enterprise value/revenue 1.91
Enterprise value/EBITDA -1.42

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-85.73%
S&P500 52-week change 3-11.01%
52-week high 312.9900
52-week low 31.2500
50-day moving average 31.6057
200-day moving average 34.0132

Share statistics

Avg vol (3-month) 3651.8k
Avg vol (10-day) 3271.33k
Shares outstanding 539.9M
Implied shares outstanding 6N/A
Float 813.39M
% held by insiders 168.61%
% held by institutions 110.57%
Shares short (14 Jun 2022) 4591.58k
Short ratio (14 Jun 2022) 44.18
Short % of float (14 Jun 2022) 42.39%
Short % of shares outstanding (14 Jun 2022) 41.48%
Shares short (prior month 12 May 2022) 4718.62k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -160.88%
Operating margin (ttm)-152.54%

Management effectiveness

Return on assets (ttm)-34.65%
Return on equity (ttm)-234.25%

Income statement

Revenue (ttm)32.19M
Revenue per share (ttm)1.13
Quarterly revenue growth (yoy)-77.30%
Gross profit (ttm)23.99M
EBITDA -45.76M
Net income avi to common (ttm)-51.78M
Diluted EPS (ttm)-1.8180
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)16.43M
Total cash per share (mrq)0.41
Total debt (mrq)12.39M
Total debt/equity (mrq)159.27
Current ratio (mrq)0.91
Book value per share (mrq)0.24

Cash flow statement

Operating cash flow (ttm)-30M
Levered free cash flow (ttm)2.31M